Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
depends the new paint I love is this kind:
https://ideapaint.com/collections/all-paints?ppc_keyword=whiteboard%20paint&gclid=CjwKCAjwoNuGBhA8EiwAFxomA3DcPz9Y1lUM67tQhEPgIrcmyxZjqO0udtMufLin85YVeB1t4KtgOBoC7dsQAvD_BwE
and writing on it about Omni has been fun for me anyway.
Lmfao I invest down like a limbo
would love to find out management has been soaking millions up over time.
Personally I believe arkady uryash is a bigger member of management/ownership than we are presently led on to.
Yes indeed reaffirms that he is not leading the charge and we will have to wait to find out who is.
Malecons old space has a laundromat moving in.
Have a great week omniers. it's a choice.
Can't wait to be in a hurricane in Florida to get it off my exotic bucket list.
wonder how Omni spent it's $1,000,000.00 Capital it raised prior to going dark. I also wonder if it raised the remaining 5,000,000.00?
Andrey took out a paultry $20,840 as a 1099 and didn't on omnis name I find this fascinating.
thanks appreciate the input.
Who's your broker!?!? TD=no-go Etrade=no-go tradestation=no-go
question: under the OTCPINK dark: limited no information designation category is omni required to disclose its PPP loan as a material event?
https://sec.report/otc/financial-report/230478/GenTech-Holdings-Financials-Disclosure-Report-07-31-19-GTEH-v2.pdf
AND what about these other 2 items highlighted below?
from the OTCMARKETS WEBSITE:
Material corporate events include:
• Entry into or termination of a material definitive agreement
• Completion of an acquisition or disposition of assets, including but not limited to merger transactions
• Creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of an
issuer
• Triggering events that accelerate or increase a direct financial obligation or an obligation under an offbalance sheet arrangement
• Costs associated with exit or disposal activities
• Material impairments
• Sales of equity securities
• Material modification to rights of security holders
• Changes in issuer's certifying accountant
• Non-reliance on previously issued financial statements or a related audit report or completed interim
review
• Changes in control of issuer
• Departure of directors or principal officers; election of directors; appointment of principal officers
https://www.pr.com/press-release/795505
• Amendments to articles of incorporation or bylaws; change in fiscal year
• Amendments to the issuer's code of ethics, or waiver of a provision of the code of ethics
• Any changes to litigation the issuer may be involved in, or any new litigation surrounding the issuer The lawsuit was never in a public filing
• Officer, director, or insider transactions in the issuer’s securities
• Disclosure regarding stock promotion campaigns deemed material by the issuer
• Other events the issuer considers to be of importance
4 months until OTCPINK DOOMS DAY, coining "OTCDD"
Some1 sold $6K today. CYA.
Dun dun dun...
here is part two of my omni/bicycle trip video thanking omni and explaining the journey.
Thank you veterans. those with family members who've sacrificed and served.
without selfless people our dreams our ambitions our nation wouldn't be the most buffed jacked up country on the planet.
days like today are why our scientific advisory board member arkady uryash works so hard on pain creams. as an isrealy Dr arkady uryash understands the need for pain management creams and especially CBD based creams.
Hey guys I think you guys will enjoy this omni video.
It's from my bicycle trip.
Andrew of omni was a big motivator in getting me to move.
so the real question is who is running operations. my hunch says arkady uryash as its his products.
but who gave the pitchdeck presentation in new york at gold fingr a couple years ago???? thats a question for MR Andrew D forbes.. he was a member of gold fingr at the time omni was pitched at the exclusive event.
this tells us what we already knew in that Andrey wasn't to remain CEO and was part of the plan for him to transition the company and explains his large stake from lx retail group.
so now we wait for merger news and much more on relaunch.
all detailed in my merger post awhile ago and indicated in company filings of this event to come.
F*** I wanna get paid to look this stuff up and compile DD for people.
I love this just don't have time for it.
Looking forward to omni taking off so I can do this full time
ANY POST RELATED TO RELIVATROL IS OMHE RELATED STICKY THIS.
C20—Pain Management
A Novel Approach in the Management of Post-Episiotomy Pain
Yisroel Grabie, OMS II1; Zara Jamil, OMS II1; Joseph Schwob, OMS II1; Boris Petrikovsky, MD, PhD1; Arkady Uryash, MD, PhD1
1New York Institute of Technology College of Osteopathic Medicine
2Garden OB/GYN
3Mount Sinai Medical Center
Statement of Significance: The first tenet of osteopathic medicine states: “The body is a unit the person is a unit of body, mind, and spirit.” Given that childbirth is a traumatic event for the mother, in addition to the fact that postpartum depression rates are considerable, it seems valuable to explore novel pain management resources using the osteopathic holistic philosophy for the treatment of postepisiotomy pain. It is our belief that in treating a mother's perineal pain, we may also improve her overall mind and spirit enhancing her wellbeing.
Methods: This pilot study was conducted in an outpatient obstetrics clinic located in Miami, F.L. involving postpartum women between the ages of 18-39 years of age, who underwent vaginal delivery with episiotomy. Spray bottles with the investigational product were distributed to the patients to manage their pain freely without regulation. A survey to assess postepisiotomy pain using the Visual Analog Scale (VAS) was administered to the patients. Pain attenuation, time to pain attenuation, and quality of pain were measured
Data Analysis: Analysis of this preliminary study indicates that Relivatrol© significantly reduced postepisiotomy pain. We are currently in the process of replicating this study on a larger scale in order to address limitations inherent to the study's design.
Results: The cohort consisted of 25 postpartum women. Of note, there were 5 women who did not respond to the treatment. The investigational product attenuated pain by an average of 3.2 scale units. Additionally, in a subgroup analysis of the “responders”, pain was attenuated by 4.0 scale units. Pre-administration pain quality was reported as sharp (n=12), achy (n=6), and dull (n=5). In the participants who responded to treatment, the average time to analgesia was reported to be 9.25 Average pain ratings after treatment were compared with average pain ratings before treatment using a unidirectional paired sample t test (df=24). The average pain ratings for the entire cohort (including non-responders) after administration of Relivatrol© were significantly lower than average pain rating prior to administration t(24)=7.41, P<.0001.
Conclusion: We concluded that Relivatrol© significantly decreases postepisiotomy pain. Since this pilot study had multiple limitations, we developed a protocol for a larger investigation involving a greater number of participants, a control arm, pharmacokinetic parameters, and an analysis of quality of life impact.
Acknowledgment/Funding Source: None reported.
References
1. Friedman AM, Ananth CV, Prendergast E, D'Alton ME, Wright JD. Variation in and Factors Associated With Use of Episiotomy. Jama. 2015;313(2):197. doi:10.1001/jama.2014.14774.
2. Tsuchiya H. Anesthetic Agents of Plant Origin: A Review of Phytochemicals with Anesthetic Activity. Molecules. 2017;22(8):1369. doi:10.3390/molecules22081369.
3. DiGiovanna EL, Schiowitz S, Dowling DJ. An Osteopathic Approach to Diagnosis and Treatment. Philadelphia, PA: Lippincott Williams and Wilkins; 2005.
4. Hieger MA, Afeld JL, Cumpston KL, Wills BK. Topical Benzocaine and Methemoglobinemia American Journal of Therapeutics. 2017; 24(5):e596-e598.American journal of therapeutics. 2017;24:e596.
promise to post your CE comments with what's actually the reason going forward after I show proof? cause otherwise my times being wasted.
you do that I'll post it. it's only fair.
well read the CE designation and what it means.
it clearly says MULTIPLE THINGS CAN EARN A CE DESIGNATION INCLUDING STOCK PROMOTION AND WE HAVE PROOF OF THIS BEING APPLICABLE.
In our case it's non of the other reasons.
for pump and dumb schemes. NOT for more serious reasons.
questionable stock promotion. nothing else.
pink limited or no information at worst.
Ran into someone who is a waiter at a south beach restaurant. he heard of omnihealth he said they had a meeting back in March.
he said thst omni is making all kinds of noise locally.
I'm so excited. we are coming to that moment where you work up to something and it's fail or fly time. it's the moment many of us have been here for so long for. and September is that moment in many ways.
it's these fly or die type out comes I honestly love and live for.
$OMHE and it's new CEO amd arkady uryash products and Andrews 44.5M share investment all comes down to defining moments of history. fkk I'm excited lol.
Oh hi securities and exchange commission so nice of you to speak over all of us. and for us on our behalf. so nice to see you have investors interests in mind just not individual investors.
knowing nothing about omni how can you be certain my investment is bad? don't tell me how to spend or waste my dollars.
wanna place a bet whether omni files something by then?
I bet they do and if they don't I'll venmo you enough for a large DQ blizzard.
OTCpink SEC crack down is looming and across the board buy and sell is restricted after that month for non compliant securities.
September deadline is looming for everyone here. exciting times.
The spread is insane holy hell. couple houndred percent
post covid launch is coming. not the reformulated cbd products but products like relivatrol etc.
I rode my bicycle 1,850+ miles.
MN TO Miami, FL pics
I Didn't drive.
there's something 100%.
let's see what happens.
I haven't gone deeper on my DD because technically not yet anyway they haven't done me dirty. if I find out otherwise I will light a fire under them by digging up everything and submit it to the SEC.
as an example the last guy who messed with me stole my scooter. I ended up in his house with his brother by my side watching tv. The guy was completely shocked and got my keys and off i Went.
With that said while I'm disappointed I still believe in positivity and good out comes. and the team they have is solid and reputable I have confirmation from locals andreys a good dude and that is worth waiting to see what happens.
oh I'm disappointed. not going to hide this fact.
even so I'm pushing harder than ever in emails to management they're viewing just not replying.
Legalization around the corner and omnis poised to benefit
Pressure on Washington to pass legalization is becoming more bi partisan.
https://www.google.com/amp/s/mjbizdaily.com/two-us-house-republicans-pitch-federal-marijuana-legalization-bill/amp/
and I want more of it. I like it I love it... easy to be negative also easy to be positive wish more would choose the ladder of the two.
*****BUYER BEWARE !!! I think you mean?
SEC has halted numerous non reporting stocks -- OMHE is a victim to malice intentioned stock promoters and has the dreaded caveat emptor label on otc markets because of a pump and dump. And should only be "otcPink little or no information"